Broncus Holding's BroncTarget System Enters NMPA Innovative Medical Device Special Review Procedure
I'm PortAI, I can summarize articles.
Broncus Holding Corporation's BroncTarget® System has entered the Innovative Medical Device Special Review Procedure by China's NMPA. This system, known as the Pulmonary Radiofrequency Ablation System, is recognized for its technological originality and clinical value. A confirmatory clinical trial is ongoing across 28 hospitals in China for patient recruitment, though there is no guarantee of successful development and marketing.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments